Maze X is an acceleration program of social impact, which aims at supporting hard-working founders who have the grit to test new ideas and aim for innovative outcomes.

This program is promoted by the Calouste Gulbenkian and the Edmond de Rothschild Foundations and the company MAZE, with PLMJ and BNP Paribas joining as corporate member, and Hospital da Luz Learning Health, Casa do Impacto as partners.

In the 2021 edition, Maze X selected ten European start-ups, of which three are Portuguese. CBR Genomics is proud of being one of these three.

Source: https://www.cbrgenomics.com/news/CBR%20Genomics%20one%20of%20the%20three%20Portuguese%20Start-ups%20of%20the%20Maze%20X%20program